Antibodies against fatty acid synthase
View Patent ↗The present invention relates to antibodies that immunospecifically bind to FAS and certain FAS related proteins. The invention encompasses human and humanized forms of the antibodies and their use in treating cancers and other proliferative disorders. The invention also relates to FAS-derived peptides useful for preparing the antibodies. Methods and compositions for detecting, diagnosing, treating or ameliorating a disease or disorder, especially cancer and other proliferative disorders using the present antibodies also are disclosed.
1. An isolated monoclonal antibody that specifically binds to the amino acid sequence of SEQ ID NO. 5.
2. The monoclonal antibody of claim 1 which is humanized.
3. A monoclonal antibody obtained by a method comprising the steps of:
a. contacting a mammal with the peptide consisting of SEQ ID NO. 5;
b. collecting cells containing the antibody from the mammal; and
c. immortalizing the cells obtained in step (b) thereby creating a hybridoma expressing the monoclonal antibodies that specifically bind to the amino acid sequence of SEQ ID NO. 5.
4. The monoclonal antibody of claim 3 wherein the mammal is immuno-compromised and the monoclonal antibody produced is a humanized antibody.
5. A method for detecting the presence or amount of a FAS protein or polypeptide in a biological sample comprising contacting the sample with the monoclonal antibody of claim 1 and determining the amount of the FAS protein bound to the monoclonal antibody.
6. The method of claim 5 wherein the monoclonal antibody is labeled with a detectable label.
7. A method for detecting the presence or amount of a FAS protein or polypeptide in a biological sample comprising contacting the sample with the monoclonal antibody of claim 2 and determining the amount of the FAS protein bound to the monoclonal antibody.
8. The method of claim 7 wherein the monoclonal antibody is labeled with a detectable label.
9. A method for detecting the presence or amount of a FAS protein or polypeptide in a biological sample comprising contacting the sample with the monoclonal antibody of claim 3 and determining the amount of the FAS protein bound to the monoclonal antibody.
10. The method of claim 9 wherein the monoclonal antibody is labeled with a detectable label.